Tag: Pivotal

Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Data from Orbit and Cosmic studies expected around the end of the year

The global logistics market size is expected to be worth approximately USD 23.14 trillion by 2034, increasing from USD 11.23 trillion in 2025, fueled by booming e-commerce, tech adoption, and infrastructure initiatives.

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential approval

The Europe off-highway electric vehicle (OHEV) market is set for remarkable growth, projected to expand from $1.39 billion in 2024 to $13.78 billion by 2034, reflecting a CAGR of 25.76%. This surge is driven by the adoption of electric equipment in mining, construction, and agriculture sectors, aligning with stringent EU emissions regulations and climate goals. This shift to electric off-highway vehicles is supported by advancements in battery technology, charging infrastructure, and government incentives, positioning these vehicles as pivotal in the region's sustainable mobility shift. Key players include AB Volvo, CNH Industrial, and Liebherr Group.